Navigation Links
Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial
Date:2/11/2008

e or unknown risks or uncertainties materialise, actual results could vary materially from the Phosphagenics' expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations.


'/>"/>
SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
5. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
6. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
11. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... China , April 16, 2015 ... leading developer, manufacturer, and marketer of medical devices ... the Securities and Exchange Commission an Annual Report on ... the year ended December 31, 2014. An electronic version ... available on Mindray,s investor relations website at  http://ir.mindray.com ...
(Date:4/16/2015)... Mass. , April 16, 2015  Hologic, ... important cervical cancer screening study i published ... a peer-reviewed journal of the American Cancer Society. ... Diagnostics and the University of Pittsburgh Medical Center, supports current ... which recommend that women 30-65 years of age ...
(Date:4/16/2015)... , April 16, 2015  Amgen (NASDAQ: AMGN ... quarter financial results on Tuesday, April 21, 2015, after ... will be followed by a conference call with the ... call from Amgen will be Robert A. Bradway ... of Amgen,s senior management team. Live audio ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
... polyphenols, as provided in, Longevinex(R), exert greater benefit than ... ... DIMAS, Calif., March 31 While molecular biologists,and news reporters present ... the advent of anti-aging pills, other,researchers report that a matrix of ...
... Venture Capital Funding, SUNNYVALE, Calif., March 31 ... difficult-to-treat blood vessels, announced,today that it has begun ... CARE II trial, as it is called, began ... and, so far, has led to,successful implantations in ...
Cached Medicine Technology:Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study 2CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent 2CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent 3
(Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog ... quotes . , Clients can review important auto ... online environment provides important advantages for clients who need ... who do not have coverage for their vehicles can ... day or hour. Many agencies offer important discounts and ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has ... "We had to run maintenance on our shipping facilities ... Ramirez, the PR Director. "It disrupted our regular shipping ... are back on track after having completed the maintenance." ... phone systems which has not allowed some calls to ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic memory foam ... help a broader range of people plagued by pain. ... most common visitors to doctors. , “The ERGO-Pedic Comfort ... relieve sitting pain. Then, only a couple months after ... later, we began getting questions from those customers, asking ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2
... to U.S., study finds , , THURSDAY, Feb. 12 (HealthDay News) ... help smokers quit cigarettes, contends a new study. , ... snus, a form of moist, powdered tobacco that,s placed under ... smokers, and Swedish men have higher smoking cessation rates than ...
... CSA ) announces the promotion of Susan ... wholly owned subsidiary, Erdman, A Cogdell,Spencer Company (Erdman). , ... office, Ms. Dorr will focus on developing,and maintaining client ... projects in the Region, which includes Georgia,Florida, Alabama, Mississippi ...
... NJ, Feb. 12 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp., ... fight infection and inflammation, today announced the results ... meeting of shareholders was called to consider a ... of the Business Corporations Act (Alberta) to reduce ...
... infects 100 million people annually reach late-stage clinical trials this ... a given vaccine candidate should protect patients from the infection, ... an article just published in the journal Clinical and ... dengue fever have expanding globally for more than 50 years, ...
... The State of Colorado has recognized Sundyne ... generous support of the Heart Gallery program to ... a subsidiary of United Technologies Corp. (NYSE: ... is supported by professional photographers who create and ...
... The Final Inch and Slumdog Millionaire show the challenges ... Astute Oscar-watchers are getting a short ... nominated films that together show the status of this ... four countries where the virus has not been stopped. ...
Cached Medicine News:Health News:Smokeless Tobacco May Not Help Smokers Quit 2Health News:Cogdell Spencer Announces Dorr as President of the Southeast Region 2Health News:Cogdell Spencer Announces Dorr as President of the Southeast Region 3Health News:NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders 2Health News:NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders 3Health News:New test may help to ensure that dengue vaccines do no harm 2Health News:New test may help to ensure that dengue vaccines do no harm 3Health News:New test may help to ensure that dengue vaccines do no harm 4Health News:New test may help to ensure that dengue vaccines do no harm 5Health News:New test may help to ensure that dengue vaccines do no harm 6Health News:Colorado Heart Gallery Places 31 Children in Adoptive Homes With Sponsorship From Sundyne 2Health News:Oscar Nominated Films Raise Polio Awareness 2
This EIA microplate opens new perspectives in the direct detection of Chlamydia. The choice of microplate immunoenzymatic technology and the use of a monoclonal antibody result in a combination of c...
... Pathfinder RSV EIA Kit is a direct antigen ... aspirates. It uses polyclonal and monoclonal antibodies ... This assay combines the specificity and reproducibility of ... an EIA. Qualitative results are availalbe within ...
... BrachyStar® Needle is designed to help you ... clinically effective brachytherapy procedure. All needles are ... and polished surfaces for smooth entry and ... and sizes assures an ideal match with ...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... flexibility of the patented SourceLink™ Connector ...
Medicine Products: